• Most Popular
  • Most Shared

FDA approves intravenous form of Merck nausea drug

Tue Jan 29, 2008 3:31pm EST

Stocks

   

NEW YORK, Jan 29 (Reuters) - Merck & Co (MRK.N) said on Tuesday that U.S. health regulators approved a new intravenous form of its anti-nausea drug Emend for patients undergoing chemotherapy.

Stocks  |  Regulatory News

The Food and Drug Administration approved injectable Emend for use in combination with other anti-nausea medicines for the prevention of acute and delayed nausea and vomiting associated with chemotherapy, Merck said.

Emend was previously available in oral capsule form. (Reporting by Bill Berkrot)

Stocks
Regulatory News


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets